reversed phase primaide hplc system (Hitachi Ltd)
Hitachi Ltd is a verified supplier 
Hitachi Ltd manufactures this product 
99
Structured Review
Hitachi Ltd
reversed phase primaide hplc system
Reversed Phase Primaide Hplc System, supplied by Hitachi Ltd, used in various techniques. Bioz Stars score: 99/100, based on 615 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/reversed+phase+primaide+hplc+system/Primaide/pm41544580-129-7-11
Average 99 stars, based on 615 article reviews
Reversed Phase Primaide Hplc System, supplied by Hitachi Ltd, used in various techniques. Bioz Stars score: 99/100, based on 615 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/reversed+phase+primaide+hplc+system/Primaide/pm41544580-129-7-11
Average 99 stars, based on 615 article reviews
reversed phase primaide hplc system - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
Purification:Article Title: Preclinical evaluation of 68 Ga-labeled acetazolamide derivatives as radiotracers targeting carbonic anhydrase IX in clear cell renal cell carcinoma. Article Snippet: Clear-cell renal cell carcinoma (ccRCC) represents the predominant histological subtype of renal carcinoma and accounts for the majority of kidney cancer-related deaths.. Conventional [18F]FDG PET frequently fails to detect ccRCC because of its intrinsically low glucose metabolism.. Carbonic anhydrase IX (CAIX), a hypoxia-inducible, tumor-specific cell-surface enzyme that is highly expressed in nearly all ccRCCs but absent from healthy kidney tissue, represents an attractive alternative target. High Performance Liquid Chromatography:Article Title: Preclinical evaluation of 68 Ga-labeled acetazolamide derivatives as radiotracers targeting carbonic anhydrase IX in clear cell renal cell carcinoma. Article Snippet: Clear-cell renal cell carcinoma (ccRCC) represents the predominant histological subtype of renal carcinoma and accounts for the majority of kidney cancer-related deaths.. Conventional [18F]FDG PET frequently fails to detect ccRCC because of its intrinsically low glucose metabolism.. Carbonic anhydrase IX (CAIX), a hypoxia-inducible, tumor-specific cell-surface enzyme that is highly expressed in nearly all ccRCCs but absent from healthy kidney tissue, represents an attractive alternative target. |